<!doctype html>
<html âš¡ lang="en">

<head>
<meta charset="utf-8">
<title>IBHRE: Clinical Practice</title>

<script async src="https://cdn.ampproject.org/v0.js"></script>
<script async custom-element="amp-sidebar" src="https://cdn.ampproject.org/v0/amp-sidebar-0.1.js"></script>
<script async custom-element="amp-accordion" src="https://cdn.ampproject.org/v0/amp-accordion-0.1.js"></script>
<script async custom-element="amp-carousel" src="https://cdn.ampproject.org/v0/amp-carousel-0.1.js"></script>
<script async custom-element="amp-bind" src="https://cdn.ampproject.org/v0/amp-bind-0.1.js"></script>
<script async custom-element="amp-video" src="https://cdn.ampproject.org/v0/amp-video-0.1.js"></script>
<script async custom-element = "amp-fit-text" src = "https://cdn.ampproject.org/v0/amp-fit-text-0.1.js"></script>
<link rel="canonical" href="https://heartrhythmbox.com/ibhre">
<meta name="viewport" content="width=device-width">
<link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.8.1/css/all.css" type="text/css"/>
<link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;600&display=swap" rel="stylesheet">

<style amp-custom>
* {
  box-sizing: border-box;
}

/*color*/
.darkCyan {background-color: #074860;color: #f1f1f1;}
.cyan1 {background-color: #1b5b56;color: #f1f1f1;}
.cyan2 {background-color: #11515b;color: #f1f1f1;}
.lime {color: #ccff00;}
.nearBlack {background-color: #232323;color: #f1f1f1;}
.lightBlue1 {background-color: #B6c2c8;color: #074860;}
.lightBlue2 {background-color: #8eafc0;color: #074860;}
.veryLightBlue {background-color: #cfd9db;color: #074860;}

/*top*/
.topBar {
    font-size: 2vmax;padding: 0.5vmax;color: #f1f1f1;
    background-color: #074860;position: sticky;top: 0;z-index: 10;
    border-bottom-left-radius: 1vmax;border-bottom-right-radius: 1vmax;   
    box-shadow: 0 1px 1px 0 rgba(0,0,0,.14), 0 1px 1px -1px rgba(0,0,0,.14), 0 1px 5px 0 rgba(0,0,0,.12);
}

.mobileOnly {display: none;}
@media only screen and (max-width:800px){
  .noMobile, .tab {display: none;}
  .mobileOnly {display: block;}
}

.tab {
  margin: 0 1.5vmax;cursor: pointer;
}
.tab a {text-decoration: none;color:#f1f1f1;}
.ref, .ref a {font-size: 1.1vw;color: #ddd;}
@media only screen and (max-width:600px) {
  .ref, .ref a {font-size: 10px;}
}

/*sideNav*/
.sideMenu {min-width: 300px;margin: 1vmax;}
.navItem {
    font-size: 1.8vmax;padding: 1vmax 2vmax 1vmax 1vmax;border: none;cursor: pointer;
    border-bottom: solid 0.1vmax rgb(112,112,112);text-align: center;
}
.navItem a {text-decoration: none;color:inherit;}
.navItem:hover, .navItem a:hover {background-color: rgb(82, 82, 82);color: #f2f2f2;}

/*flexbox */
.row {display: flex;align-content: center;flex-wrap: wrap;}
.row800 {display: flex;padding: 1vmax;}
@media only screen and (max-width:800px) {
  .row800 {display: none;}
}

/*list*/
.lightList, .darkList {font-size: 2.5vmax;font-weight: 600;padding: 2vmax; text-align: center;color: #ccff00;margin: 1vmax;}
.lightList li, .darkList li {
  font-size: 1.8vmax;font-weight: normal;border-bottom: #ddd 0.1vmax solid;color: #ddd;padding: 1vmax;
  list-style: none;
  }
  .lightList li a, .darkList li a {text-decoration: none;color: inherit;}
.darkList {color: #074860;}
.lightList li:hover, .darkList li:hover  {background-color: #074860;color: #ffffff;}
.darkList li {color: #232323;border-bottom-color: #555;}
@media only screen and (min-width:801px){
  .darkList, .lightList, .lightList li, .darkList li {padding: 0.5vmax;font-size: 2.5vmax;}
}
@media only screen and (max-width:800px){
  .darkList, .lightList, .lightList li, .darkList li {padding: 0.5vmax;}
}

/*Q*/
.qBox {text-align: left;margin-left: auto;margin-right: auto;padding: 2vmax;}
.qList {list-style: lower-alpha inside; border-top: #ccff00 0.1vmax solid;padding: 1vmax;
margin-left: auto;margin-right: auto;}

/*table*/
.lightTable {text-align: left;border-collapse: collapse;padding: 1vmax 2vmax;color: #f2f2f2;
margin-bottom: 5vh;margin-right: auto;margin-left: auto;}
.lightTable th, .lightTable td {border-bottom: #ddd 0.1vmax solid;padding: 1vmax 2vmax;}
.lightTable th {color: #ccff00;}
@media only screen and (max-width:500px){
  .lightTable {margin: none;padding: 0.25vw;}
  .lightTable th, .lightTable td {padding: 0.25vw;}
}


/*accordion*/
.main {font-size: 2vmax;padding: 1vmax;}
.main h4 {padding: 1vmax;border: none;}

amp-accordion {margin-left: auto;margin-right: auto;text-align: center;width: fit-content;
padding: 5vh 0;margin-top: 5vh;margin-bottom: 5vh;}
amp-accordion section[expanded] .showMore {display: none;}
amp-accordion section[expanded] .showLess {color: #ccff00;}
amp-accordion section:not([expanded]) .showLess {display: none;}

/*carousel*/
    /* define some contants */
  amp-carousel {max-height: 90vh;}
    .collapsible-captions {
      --caption-height: 2vmax;
      --image-height: 300px;
      --button-size: 1.5vmax;
      --caption-color: #f5f5f5;;
      font-size: 1.8vmax;
    }
    .collapsible-captions * {
      /* disable chrome touch highlight */
      -webkit-tap-highlight-color: rgba(255, 255, 255, 0);
      box-sizing: border-box;
    }
    .collapsible-captions {
      position: relative;
      width: 100%;
    }
    .collapsible-captions amp-img img {
      object-fit: contain;
    }
    .collapsible-captions figure {
      margin: 0;
      padding: 0;
      background-color: #333;
    }
    /* single line caption */
    .collapsible-captions figcaption {
      position: absolute;
      bottom: 0;
      margin: 0;
      width: 100%;
      /* inital height is one line */
      max-height: var(--caption-height);
      line-height: var(--caption-height);
      padding: 0 var(--button-size);
      /* cut text after first line and show an ellipsis */
      white-space: nowrap;
      overflow: hidden;
      text-overflow: ellipsis;

      /* overlay the carousel icons */
      z-index: 10;
      /* some styling */
      color: var(--caption-color);
      background-color: rgba(17,17,17,0.6);
    }
    /* expanded caption */
    .collapsible-captions figcaption.expanded {
      /* add padding and show all of the text */
      line-height: inherit;
      white-space: normal;
      text-overflow: auto;
      max-height: calc(var(--caption-height) + var(--image-height));
      /* show scrollbar in case caption is larger than image */
      overflow: auto;
      background-color: rgba(17,17,17,0.9);
    }
    /* don't show focus highlights in chrome */
    .collapsible-captions figcaption:focus {
      outline: none;
      border: none;
    }
    /* the expand/collapse icon */
    .collapsible-captions figcaption span {
      display: block;
      position: absolute;
      top: calc((var(--caption-height) - var(--button-size)) / 2);
      right: 0.5vw;
      width: var(--button-size);
      height: var(--button-size);
      line-height: var(--button-size);
      text-align: center;
      font-size: 1.8vmax;
      color: white;
      cursor: pointer;
    }


/*footer*/
.rowF {display: flex;padding: 1vmax;border-bottom: #ddd solid 0.5px;}
.sectionH {padding-top: 0.7vmax;
        background-color: transparent;color: white;font-size: 16px;border: none;
      }
.sectionT {
        font-size: 14px;color: #f1f1f1;padding: 0.7vmax;
      }

</style>

<style amp-boilerplate>body{-webkit-animation:-amp-start 8s steps(1,end) 0s 1 normal both;-moz-animation:-amp-start 8s steps(1,end) 0s 1 normal both;-ms-animation:-amp-start 8s steps(1,end) 0s 1 normal both;animation:-amp-start 8s steps(1,end) 0s 1 normal both}@-webkit-keyframes -amp-start{from{visibility:hidden}to{visibility:visible}}@-moz-keyframes -amp-start{from{visibility:hidden}to{visibility:visible}}@-ms-keyframes -amp-start{from{visibility:hidden}to{visibility:visible}}@-o-keyframes -amp-start{from{visibility:hidden}to{visibility:visible}}@keyframes -amp-start{from{visibility:hidden}to{visibility:visible}}</style><noscript><style amp-boilerplate>body{-webkit-animation:none;-moz-animation:none;-ms-animation:none;animation:none}</style></noscript>
<script async custom-element="amp-auto-ads"
        src="https://cdn.ampproject.org/v0/amp-auto-ads-0.1.js">
</script>
<script async custom-element="amp-analytics" src="https://cdn.ampproject.org/v0/amp-analytics-0.1.js"></script>

</head>

<body style="font-family: 'Inter', sans-serif;color: rgb(82, 82, 82);">

  <amp-auto-ads type="adsense"
  data-ad-client="ca-pub-1548733331544768">
  </amp-auto-ads>
  <amp-analytics type="googleanalytics" config="https://amp.analytics-debugger.com/ga4.json" data-credentials="include">
    <script type="application/json">
    {
        "vars": {
                    "GA4_MEASUREMENT_ID": "G-PHBZ8EJY6J",
                    "GA4_ENDPOINT_HOSTNAME": "www.google-analytics.com",
                    "DEFAULT_PAGEVIEW_ENABLED": true,    
                    "GOOGLE_CONSENT_ENABLED": false,
                    "WEBVITALS_TRACKING": false,
                    "PERFORMANCE_TIMING_TRACKING": false,
                    "SEND_DOUBLECLICK_BEACON": false
        }
    }
    </script>
    </amp-analytics>

  <amp-sidebar id="sidebar" layout="nodisplay" side="left">
    <div style="text-align: left;padding: 0.5vmax;">
    <button on="tap:sidebar.close" style="border: none;">
        <i class="fas fa-times-circle" style="font-size: 2vmax;color: rgb(27, 91,86);border:none"></i>
    </button>
    </div>
    <div class="sideMenu">
    <ul style="list-style: none;margin: 0;padding: 0;">
        <li class="navItem"><a href="Index.html" target="_blank">Home</a></li>
        <li class="navItem"><a href="EP.html" target="_blank">Fundamental of EP</a></li>
        <li class="navItem"><a href="ECG.html" target="_blank">ECGs</a></li>
        <li class="navItem"><a href=#top>Clinical Practice</a></li>
        <li class="navItem" style="border-bottom: none;">
            <a href="https://heartrhythmbox.com" target="_blank">
                <amp-img src="box_grey.png" width="32" height="32" layout="fixed">
                </amp-img></a>    
        </li>
    </ul></div>
</amp-sidebar>

<!--large screen only --menu-->
<div class="topBar row800" style="font-size: 1.8vmax;">
  <button on="tap:sidebar.open" class="darkCyan" style="border: none;cursor: pointer;">
    <i class="fas fa-bars" style="font-size: 1.8vmax;color: #ccff00;"></i></button>
  <span style="top: 0.5vmax;right: 1vmax;position: absolute;">
    <a href="https://heartrhythmbox.com" target="_blank">
    <amp-img src="box_grey.png" width="30" height="30" layout="fixed">
        </amp-img></a>
  </span>
  <div class="tab">
    <a href="Index.html" target="_blank">
    Home</a>
  </div>
  <div class="tab">
    <a href="EP.html" target="_blank">Fundamental of EP</a>
  </div>
  <div class="tab">
    <a href="ECG.html" target="_blank">
    ECGs</a>
  </div>
  <div class="tab" style="border-bottom:#ccff00 solid 0.2vmax">
    <a href=#top>
    Clinical Practice</a>
  </div>
</div>

<!--mobile menu-->
<div class="topBar mobileOnly" style="width: 100%;">
  <button on="tap:sidebar.open" style="border: none;cursor: pointer;" class="darkCyan lime">
  <i class="fas fa-bars" style="font-size: 2vmax;"></i></button>
  <span style="top: 0.5vmax;right: 1vmax;position: absolute;">
    <a href="https://heartrhythmbox.com" target="_blank">
    <amp-img src="box_grey.png" width="20" height="20" layout="fixed">
        </amp-img></a>
    </span>
</div>

<!--title-->
<div style="font-size: 3.2vmax;letter-spacing: 0.5vmax;font-weight: 600;text-align: center;padding: 1vmax;">
  Clinical Practice
 </div>

<!--content-->
 <amp-accordion animate expand-single-section>
        
<!--Guidelines-->
<section class="main nearBlack" expanded>
    <h4 class="nearBlack">
    <span class="showMore"><i class="fas fa-chevron-circle-down"></i>&nbsp; </span>
    <span class="showLess"><i class="fas fa-chevron-circle-up"></i>&nbsp; </span>  
    Guidelines & Exam Blueprint</h4>
    
    <amp-carousel class="collapsible-captions" height="54vw" width="96vw" layout="fixed" type="slides" 
    style="margin-left: auto;margin-right: auto;">
    
    <!--guidelines-->
    <figure>
    <amp-fit-text width="86vw" height="40vw" layout="responsive">
    <ul class="lightList">
      <!--li>
        <a href="https://doi.org/10.1093/eurheartj/ehw128" target="_blank">
          2016 ESC Guidelines for <span class="noMobile">the diagnosis and treatment of acute and chronic</span>
        <span class="lime" style="font-weight: 600;letter-spacing: 0.5vmax;">&nbsp;HEART FAILURE</span></a>
      </li-->
       <li>
            <a href="https://doi.org/10.1161/CIR.0000000000000549" target="_blank">
            2017 AHA/ACC/HRS Guideline for <span class="noMobile">Management of Patients With Ventricular Arrhythmias and the Prevention of </span>
            <span class="lime" style="font-weight: 600;letter-spacing: 0.5vmax;">&nbsp;SUDDEN CARDIAC DEATH</span></a>
        </li>
        <li>
            <a href="https://doi.org/10.1161/CIR.0000000000000499" target="_blank">
            2017 ACC/AHA/HRS Guideline for <span class="noMobile">the Evaluation and Management of Patients With </span>
            <span class="lime" style="font-weight: 600;letter-spacing: 0.5vmax;">&nbsp;SYNCOPE</span></a>
        </li>
        <li>
            <a href="https://doi.org/10.1016/j.jacc.2018.10.044" target="_blank">
            2018 ACC/AHA/HRS Guideline on <span class="noMobile">the Evaluation and Management of Patients With </span>
            <span class="lime" style="font-weight: 600;letter-spacing: 0.5vmax;">&nbsp;BRADYCARDIA</span></a>
        </li>
        <li>
          <a href="https://doi.org/10.1093/europace/euaa367" target="_blank">
          2021 EHRA/HRS/APHRS/LAHRS EHRA expert consensus statement <span class="noMobile">and practical guide on optimal </span>
          <span class="lime" style="font-weight: 600;letter-spacing: 0.5vmax;">&nbsp;on optimal implantation techniques</span></a>
      </li>

      <li>
        <a href="https://doi.org/10.1161/CIR.0000000000001063" target="_blank">
          2022 AHA/ACC/HFSA Guideline for the Management of 
        <span class="lime" style="font-weight: 600;letter-spacing: 0.5vmax;text-transform: uppercase;">&nbsp;Heart Failure</span></a>
    </li>
    </ul>
    </amp-fit-text>
    <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
    <b>ACC/AHA/HRS: Device Guidelines</b>
    <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
    </figcaption>
    </figure>
    
    <!--blueprint-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\blueprintClinicalPractice.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Exam Blueprint for cardiac device specialists</b><br>
      <i class="ref">
        Ref: <a href="https://ibhre.org/sites/default/files/2021-04/3.10.2021-Candidate-Handbook-Final.pdf" target="_blank">
        IBHRE Candidate Handbook
        </a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
      </figure>

    </amp-carousel>
</section>

<!--Brady-->
<section class="main darkCyan">
    <h4 class="darkCyan">
    <span class="showMore"><i class="fas fa-chevron-circle-down"></i>&nbsp; </span>
    <span class="showLess"><i class="fas fa-chevron-circle-up"></i>&nbsp; </span>  
    Pacemaker Indications</h4>
    
    <amp-carousel class="collapsible-captions" height="54vw" width="96vw" layout="fixed" type="slides" 
    style="margin-left: auto;margin-right: auto;">

    <!--def-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\sndDef.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Definition</b><br>
      <i class="ref">
        <a href="https://doi.org/10.1016/j.jacc.2018.10.044" target="_blank">
          2018 ACC/AHA/HRS Guideline on BRADYCARDIA</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
      </figure>

    <!--def-->
    <figure>
    <amp-img layout="fill" src="media\Clinical\avBlockDef.png"></amp-img>
    <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
    <b>Definition</b><br>
    <i class="ref">
      <a href="https://doi.org/10.1016/j.jacc.2018.10.044" target="_blank">
        2018 ACC/AHA/HRS Guideline on BRADYCARDIA</a>
    </i>
    <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
    </figcaption>
    </figure>

    <!--init Dx algo-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\initDxAlgo.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Bradycardia Evaluation Algorithm</b><br>
      Noted that sleep apnea is now recognized as one of the conditions that causes bradycardia.<br>
      For those who had infrequent symptoms, implantable cardiac monitor (ICM) is recommended.<br>
      <i class="ref">
        <a href="https://doi.org/10.1016/j.jacc.2018.10.044" target="_blank">
          2018 ACC/AHA/HRS Guideline on BRADYCARDIA</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <!--SSS algo-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\sndAlgo.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Sinus Node Dysfunction Management</b><br>
      Pacemaker is indicated only in symptomatic patients.
      <i class="ref">
        <a href="https://doi.org/10.1016/j.jacc.2018.10.044" target="_blank">
          2018 ACC/AHA/HRS Guideline on BRADYCARDIA</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <!--SSS algo mode-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\ppmModeSND.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Choices of Pacemaker in SND</b><br>
      For those with symptomatic SND that is short-lived or infrequent, single chamber ventricular pacing including leadless pacemaker may be adequate.<br>
      The risk of developing AV block after PPM is 3-35%, depending on underlying bundle branch conduction abnormalities.
      <i class="ref">
        <a href="https://doi.org/10.1016/j.jacc.2018.10.044" target="_blank">
          2018 ACC/AHA/HRS Guideline on BRADYCARDIA</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <!--avb algo-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\avbAlgo.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Management of AV Block</b><br>
      Symptoms of severe 1st degree AV block (PR >0.30s) and Mobitz I are similar to those of pacemaker syndrome. 
      The indication for PPM is driven by symptoms.<br> 
      For those with infranodal block (Mobitz II, advanced, or complete AV block) not from reversible causes, PPM is indicated regardless of symptoms.<br>
      <i class="ref">
        <a href="https://doi.org/10.1016/j.jacc.2018.10.044" target="_blank">
          2018 ACC/AHA/HRS Guideline on BRADYCARDIA</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <!--avb algo mode-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\ppmModeAvb.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Choices of PPM in AV Block</b><br>
        In AV Block with LVEF&lt;50% and expected frequent RV pacing (&gt;40%), CRT or His-bundle pacing are preferred.<br>
      <i class="ref">
        <a href="https://doi.org/10.1016/j.jacc.2018.10.044" target="_blank">
          2018 ACC/AHA/HRS Guideline on BRADYCARDIA</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <!--lyme-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\Lyme.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Lyme Carditis</b><br>
        Lyme carditis is one of the most common reversible causes of AV block.Approximately 40%
        of patients who are identified clinically require temporary pacing, but permanent atrioventricular block
        after antibiotic therapy is rare.<br>
      <i class="ref">
        <a href="https://doi.org/10.1016/j.jacc.2018.11.035" target="_blank">
          JACC 2019.</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <!--post TAVR-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\postTAVR.jpeg"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>PPM post TAVR</b><br>
        PPM is class I for persisted high-grade AVB or new alternating BBB.<br>
        New conduction abnormalities included transient high-degree AVB, PR prolongation, or axis change.
        In patients with pre-existing RBBB + new conduction abnormalities, PPM may be considered (IIa).<br>
      <i class="ref">
        <a href="https://doi.org/10.1093/eurheartj/ehab364" target="_blank">
          2021 ESC Guidelines for pacing & CRT</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <!--leadless-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\leadless.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      Leadless Pacemaker  <br> 
      <i class="ref">
        <a href="https://doi.org/10.1093/eurheartj/ehab364" target="_blank">
        2021 ESC Guidelines for Cardiac Pacing</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <!--externalized TVP-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\tvpExt.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      Temporary Transvenous Paceamker<br> 
      For a long term need, consider temporary pacemaker using exteriorized active fixation lead.<br>
      <i class="ref">
        <a href="https://doi.org/10.1093/europace/eut045" target="_blank">
          EP Europace, September 2013</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    </amp-carousel>
</section>

<!--ICD-->
<section class="main cyan2">
    <h4 class="cyan2">
    <span class="showMore"><i class="fas fa-chevron-circle-down"></i>&nbsp; </span>
    <span class="showLess"><i class="fas fa-chevron-circle-up"></i>&nbsp; </span>  
    ICD Indications</h4>
    
    <amp-carousel class="collapsible-captions" height="54vw" width="96vw" layout="fixed" type="slides" 
    style="margin-left: auto;margin-right: auto;">
    
    <!--ICD 2nd-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\icdSecond.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>ICD for Secondary Prevention in Patients with Ischemic Heart Disease</b><br>
      Need to exclude reversible causes.<br>
      ICD candidacy determined by functional status, life expectancy, or patient preference.
      <i class="ref">
        <a href="https://doi.org/10.1161/CIR.0000000000000549" target="_blank">
          2017 AHA/ACC/HRS Guideline for Sudden Cardiac Death</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <!--ICD 1ry-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\icdPrim.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>ICD for Primary Prevention in Patients with Ischemic Heart Disease</b><br>
      Early ICD implantation may consider in those with pacing indication or syncope.
      <i class="ref">
        <a href="https://doi.org/10.1161/CIR.0000000000000549" target="_blank">
          2017 AHA/ACC/HRS Guideline for Sudden Cardiac Death</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <!--NICM-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\icdNICM.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>ICD for non-Ischemic Heart Disease</b><br>
      In Lamin A/C mutation, ICD may be beneficial in those with 2 or more risk factors (NSVT, LVEF&lt;45%, non-missense mutation, and male sex). 
      <i class="ref">
        <a href="https://doi.org/10.1161/CIR.0000000000000549" target="_blank">
          2017 AHA/ACC/HRS Guideline for Sudden Cardiac Death</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <!--HCM-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\HCM.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>ICD for Hypertrophic Cardiomyopathy</b><br>
      HCM is the most common cause of SCD in individuals &lt;40 years of age.
      <i class="ref">
        <a href="https://doi.org/10.1161/CIR.0000000000000549" target="_blank">
          2017 AHA/ACC/HRS Guideline for Sudden Cardiac Death</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <!--LQTS-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\LQTS.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>ICD for Hypertrophic Cardiomyopathy</b><br>
      Beta blocker is the 1st line therapy for both primary and secondary prevention.
      Nadolol is the most favorable agent.
      <br>
      <i class="ref">
        <a href="https://doi.org/10.1161/CIR.0000000000000549" target="_blank">
          2017 AHA/ACC/HRS Guideline for Sudden Cardiac Death</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <!--LQT drugs-->
    <figure>
      <amp-fit-text width="80vw" height="40vw" layout="responsive">
      <table class="lightTable">
        <tr>
          <th>Drug Class</th><th>Examples</th>
        </tr>
        <tr>
          <td>Antiarrhythmics</td><td>class Ia and class III</td>
        </tr>
        <tr>
          <td>Psychotropic Medications</td><td>Haloperidol, Citalopram, Tricyclic Antidepressants</td>
        </tr>
        <tr>
          <td>Antibiotics</td><td>Erythromycin, Azithromycin, Ciprofloxacin, Levofloxacin, Fluconazole</td>
        </tr>
        <tr>
          <td>Antiemetics</td><td>Domperidone, Ondansetron</td>
        </tr>
        <tr>
          <td>Others</td><td>Methadone</td>
        </tr>
      </table>
      </amp-fit-text>
      
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Commonly used QT-prolonging Medications</b><br>
      <i class="ref">More complete list at
        <a href="https://www.crediblemeds.org/" target="_blank">
          crediblemeds.com</a>
      or download <a href="media\Clinical\Drugs To Avoid List in LQTS.pdf" target="_blank"> pdf version here</a></i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <!--subQ-->
    <figure>
      <div class="row">
      <amp-img layout="responsive" width="1" height="1" src="media\Clinical\subQICD.png" style="display: flex;flex: 0.8;"></amp-img>
      <div style="display: flex;flex: 1.2;">
      <ul class="lightList">
        Entirely Subcutanous ICD
        <li>Avoid need for venous access.</li>
        <li class="noMobile">May not achieve adequate sensing in all patients.</li>
        <li>No ATP or continous pacing support.</li>
        <li>May be appropriate in HCM, Brugada, and congenital heart patients.</li>
      </ul>
      </div>
      </div>  
    </figure>

    <!--TOF-->
    <figure>
      <div class="row">
      <amp-img layout="responsive" width="468" height="519" src="media\Clinical\TOF.webp" style="display: flex;flex: 0.8;"></amp-img>
      <amp-img layout="responsive" width="1" height="0.5" src="media\Clinical\Tetralogy-of-Fallot-Medcomic.jpg" style="display: flex;flex: 1.2;"></amp-img>
      </div>  
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
        <b>Tetralogy of Fallot</b><br>
        The most common cyanotic congenital heart disease in grown-up adult.
        <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
        </figcaption>
    </figure>

    <!--ACHD-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\ACHD ICD.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>ICD in Adult Congenital Heart Disease</b><br>
      *High-risk features: prior palliative systemic to pulmonary shunts, unexplained syncope, frequent PVC, atrial tachycardia, QRS duration â‰¥180 ms, decreased LVEF or diastolic dysfunction, dilated right ventricle, severe pulmonary regurgitation or stenosis, or elevated levels of BNP.
      <br>
      <i class="ref">
        <a href="https://doi.org/10.1161/CIR.0000000000000549" target="_blank">
          2017 AHA/ACC/HRS Guideline for Sudden Cardiac Death</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>
    
    </amp-carousel>
</section>

<!--CRT-->
<section class="main cyan1">
    <h4 class="cyan1">
    <span class="showMore"><i class="fas fa-chevron-circle-down"></i>&nbsp; </span>
    <span class="showLess"><i class="fas fa-chevron-circle-up"></i>&nbsp; </span>  
    CRT & Conduction System Pacing Indications</h4>
    
    <amp-carousel class="collapsible-captions" height="54vw" width="96vw" layout="fixed" type="slides" 
    style="margin-left: auto;margin-right: auto;">
    
    <!--algo-->
    <figure>
    <amp-img layout="fill" src="media\Clinical\crtAlgo.png"></amp-img>
    <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
    <b>Indications for CRT Therapy</b><br>
    <i class="ref">
      <a href="https://doi.org/10.1161/CIR.0000000000001063" target="_blank">
      2022 ACC Guidelines for HF</a>
    </i>
    <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
    </figcaption>
    </figure>

    <figure>
      <amp-img layout="fill" src="media\Clinical\QRSandLBBB.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Benefits of CRT in LBBB</b> &nbsp;varied by the duration of QRS. 
      The benefit began in QRS&gt;120ms and became clearer in QRS&ge;150ms.<br>
      <i class="ref">
        <a href="https://doi.org/10.1161/circheartfailure.113.000380" target="_blank">
        Results from RAFT. Circ Heart Failure 2013.</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <figure>
      <amp-img layout="fill" src="media\Clinical\QRSandNLBBB.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Benefits of CRT in non-LBBB</b> &nbsp;is less than that of LBBB. 
      <br>
      <i class="ref">
        <a href="https://doi.org/10.1161/circheartfailure.113.000380" target="_blank">
        Results from RAFT. Circ Heart Failure 2013.</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <!--figure>
      <amp-img layout="fill" src="media\Clinical\crtIndicationsEsc.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Indications for CRT Therapy in brief</b><br>
      <i class="ref">
        <a href="https://doi.org/10.1093/eurheartj/ehw128" target="_blank">
        2016 ESC Guidelines for HF</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure-->

    <figure>
      <amp-img layout="fill" src="media\Clinical\crtLeadPosition.jpg"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Classification of LV Lead Position</b><br>
      <i class="ref">
        <a href="https://doi.org/10.1161/CIRCULATIONAHA.110.000646" target="_blank">
        Circulation 2011.</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <figure>
      <amp-img layout="fill" src="media\Clinical\apicalLVLead.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Apical LV lead position</b> was associated with higher incidence of HF or death compared to non-apical position.<br>
      <i class="ref">
        <a href="https://doi.org/10.1161/CIRCULATIONAHA.110.000646" target="_blank">
        Circulation 2011.</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <figure>
      <amp-img layout="fill" src="media\Clinical\HBP ECGs.jpeg"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Selective His bundle pacing (S-HBP)</b> is easily recognized by an isoelectric interval (corresponding to the HV) between the pacing spike and QRS onset, 
      whereas with non-selective HBP, a â€˜pseudo-deltaâ€™ wave is observed due to capture of local myocardium.<br>
      <i class="ref">
        <a href="https://doi.org/10.1093/eurheartj/ehab364" target="_blank">
        2021 ESC Guidelines for Cardiac Pacing</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <figure>
      <amp-img layout="fill" src="media\Clinical\HisAlternative.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      2021 Guidelines recommended HBP as an alternative to CRT (IIA) while awaiting more data from both HBP and left bundle branch area pacing. 
        <i class="ref">
        <a href="https://doi.org/10.1093/eurheartj/ehab364" target="_blank">
        2021 ESC Guidelines for Cardiac Pacing</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    </amp-carousel>
</section>

<!--procedure-->
<section class="main lightBlue2">
    <h4 class="lightBlue2">
    <span class="showMore"><i class="fas fa-chevron-circle-down"></i>&nbsp; </span>
    <span class="showLess"><i class="fas fa-chevron-circle-up"></i>&nbsp; </span>  
    Device Implantation: Procedural Considerations</h4>
    
    <amp-carousel class="collapsible-captions" height="54vw" width="96vw" layout="fixed" type="slides" 
    style="margin-left: auto;margin-right: auto;">

    <!--preop checklist-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\preOpCheckList.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Preoperative Checklist</b><br>
      <i class="ref">
      <a href="https://doi.org/10.1093/europace/euaa367" target="_blank">
        2021 EHRA consensus on optimal implantation techniques</a></i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
      </figure>

    <!--OAC/antiplt-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\periOpOACs.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Preoperative Management of Anticoagulation and Antiplatelets</b><br>
      Hemetoma increases risk of infection. 
      Uninteruppted oral anticoagulation is preferrable to heparin briding, as it reduces risk of hematoma.<br>
      For DOAC, incidence of hemaroma was not different between interupted and uninteruppted strategy. <br>
      <i class="ref">
        <a href="https://doi.org/10.1093/europace/euaa367" target="_blank">
          2021 EHRA consensus on optimal implantation techniques</a></i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
      </figure>

    <!--venous access-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\venousAccess.jpg"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Venous Access for Lead Insertion</b><br>
      A venogram has been performed from the left antecubital fossa (top panel). This shows the drainage into the cephalic vein, axillary vein, running over the first rib, and then into the subclavian vein.
      <i class="ref">
        <a href="http://dx.doi.org/10.1136/hrt.2007.132753" target="_blank">
          Heart 2009;95:259-264.
        </a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
      </figure>

    <!--pocket plane-->
    <figure>
      <amp-img layout="fill" src="media\QA\Q19 pocket-layers-diagram.jpg"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Tissue plane for appropriate device implantation</b><br>
      Most common: Subcutaneous pocket = below fat and above muscles. 
      <i class="ref">
        <a href="howtopace.com" target="_blank">
          howtopace.com
        </a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
      </figure>

    <!--anatomy RAA/RVOT-->
    <figure>
    <amp-img layout="fill" src="media\Clinical\anatomy.png"></amp-img>
    <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
    <b>Anatomy of the heart chambers relevant for pacing</b><br>
    Right anterior oblique view (âˆ¼20Â°) of the heart. Note proximity of the tip (*) of the right atrial appendage (RAA) to the aortic root (Ao) and the right ventricle.
    The pacing lead is positioned on the mid-septum against the septo-marginal trabeculation (SMT) below the supraventricular crest (SVcrest), which forms the inferior border of the right ventricular outflow tract (RVOT). A noticeable Â«jumpÂ» can be seen as the lead is pulled back from the RVOT over these structures.
    <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
    </figcaption>
    </figure>

    <!--CS-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\csAnatomy.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Anatomy of Coronary Sinus</b>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <!--drugs-->
    <figure>
      <!-- Ref: https://amp.dev/documentation/components/amp-fit-text/ -->
      <amp-fit-text width="80vw" height="40vw" layout="responsive">
        <Table class="lightTable">
          <div class="lightBlue1" style="padding: 1vmax;text-align: center;font-weight: 600;">Common Medications administered during Device Implantation</div>
          <tr>
            <th>Roles</th><th>Examples</th>
          </tr>
          <tr>
            <td>Antibiotics</td><td>Cefazolin, Cloxacillin, Vancomycin</td>
          </tr>
          <tr>
            <td>Analgesic</td><td>Morphine derivatives such as fentanyl</td>
          </tr>
          <tr>
            <td>Sedative and Amnestic</td><td>Benzodiazepines (BZP; such as midazolam)</td>
          </tr>
          <tr>
            <td>Antidotes</td><td>Flumazenil (against BZP), Naloxone (against Morphine group)</td>
          </tr>
        </Table>
      </amp-fit-text>
    </figure>

    <!--CS-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\atbTiming.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Timing of Antiobiotics before surgery</b><br>
      Preop antibiotic is recommended within 1 hr of skin incision.<br>
      <a href="https://doi.org/10.4414/smw.2012.13616" class="ref">
        Swiss Med Wkly. 2012;142:w13616
      </a>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <!--sterile tech 1-->
    <figure>
      <div class="nearBlack" style="font-weight: 600;font-size: 2.2vmax;padding: 1vw;">Sterile Techniques (1/2)</div>
      <div class="row">
      <amp-img layout="responsive" width="638" height="359" 
      src="media\Clinical\sterileField.png" style="flex: 1;padding: 0.5vw;"></amp-img>
      <div class="noMobile" style="flex: 1;">
      <ul class="lightList">
        <li>Tables draped as part of a sterile field are considered sterile only at the table level.</li>
        <li>Anything out of your range of vision or below waist level is considered contaminated and unsterile.</li>
        <li>If there are any questions or doubts about an object's sterility, the object should be considered unsterile.</li>
      </ul>
      </div>
      </div>
    </figure>

    <!--sterile tech 2-->
    <figure>
      <div class="nearBlack" style="font-weight: 600;font-size: 2.2vmax;padding: 1vw;">Sterile Techniques (2/2)</div>
      <div class="row">
      <amp-img layout="responsive" width="2448" height="3264" 
      src="media\Clinical\pkgOpening.png" style="flex: 1;padding: 0.5vw;"></amp-img>
      <div class="noMobile" style="flex: 1;">
      <ul class="lightList">
        <li>Once a package is opened, a 2.5 cm (1 inch) border around the edge is considered unsterile.</li>
        <li>A sterile object or field can become contaminated by lingering exposure to air.</li>  
        <li>A sterile barrier that has been compromised by punctures, tears or moisture has to be considered contaminated.</li>
      </ul>
      </div>
      </div>
    </figure>

    <!--Rad Dose-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\radDose.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Typical Radiation Dose of some sources of radiation</b><br>
      The absolute lifetime risk of fatal cancer for an adult increases by 0.05% for every 10 mSv of exposure.<br>
      <i class="ref">
        <a href="https://doi.org/10.1093/europace/eut409" target="_blank">
        EP Europace 2014.</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <!--radiation safety-->
    <figure>
      <div class="nearBlack" style="font-weight: 600;font-size: 2.2vmax;padding: 1vw;">Radiation Safety (1/2)</div>
      <div class="row">
      <amp-img layout="responsive" width="768" height="307" 
      src="media\Clinical\ALARA.png" style="flex: 1;padding: 0.5vw;"></amp-img>
      <div class="noMobile" style="flex: 1;">
      <ul class="lightList">
        <li>"ALARA" or "as low as reasonably achievable" Principle</li>
        <li>Even if it is a small dose, if receiving that dose has no direct benefit, you should try to avoid it. </li>
        <li>3 basic protective measures: time, distance, and shielding.</li>
        </ul>
      </div>
      </div>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
        <i class="ref">Ref:
          <a href="https://www.nrc.gov/about-nrc/radiation/protects-you/protection-principles.html" target="_blank">
          US Nuclear Regulatory Commission
          </a>
        </i>
        <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <!--radiation safety 2-->
    <figure>
      <div class="nearBlack" style="font-weight: 600;font-size: 2.2vmax;padding: 1vw;">Radiation Safety (2/2)</div>
      <div class="row">
      <amp-img layout="responsive" width="850" height="672" 
      src="media\Clinical\invSqLaw.png" style="flex: 0.8;margin: 0.5vw;"></amp-img>
      <amp-img layout="responsive" width="709" height="241" 
      src="media\Clinical\radExposureLevel.png" style="flex: 1.2;margin: 0.5vw;"></amp-img>
      </div>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
        The radiation Intensity is inversely proportional to the square of the distance.
        <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <!--DFT-->
    <figure>
        <amp-img layout="fill" src="media\Clinical\DFT effects of energy.png"></amp-img>
        <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
        <b>Concept of defibrillation threshold testing: DFT vs. ULV</b><br>
        The effects of an electrical shock vary as a function of the energy delivered. A low-energy shock, on the order of 1 Joule (J), delivered in the vulnerable period, can induce an arrhythmia. The upper limit of vulnerability corresponds to the lowest shock energy, which, when delivered during the ventricular vulnerable period, does not induce VF, a value that has been correlated with the defibrillation threshold.<br>
        <i class="ref">
          <a href="www.cardiocases.com" target="_blank">
            cardiocases.com
          </a>
        </i>
        <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
        </figcaption>
    </figure>

    <!--DFT indications-->
    <figure>
      <amp-fit-text width="80vw" height="40vw" layout="responsive">
        <table class="lightTable" style="margin-bottom: auto;">
          <tr>
            <th>Conditions</th><th>DFT (Yes/No)</th><th>Class of Recommendation</th>
          </tr>
          <tr>
            <td>Subcutanous</td><td>Yes</td><td>I</td>
          </tr>
          <tr>
            <td>Initial left-pectoral, transvenous implantation with well-positioned RV lead and adequate sensing.</td>
            <td>No</td><td>IIa</td>
          </tr>
          <tr>
            <td>Right-pectoral implantation or generator change.</td><td>Yes</td><td>IIa</td>
          </tr>
          <tr>
            <td>Contraindications to DFT*</td><td>No</td><td>III</td>
          </tr>
        </table>
        <div class="ref" style="text-align: left;padding: 1vmax;">*documented nonchronic cardiac thrombus, AF or atrial flutter without adequate systemic anticoagulation, critical aortic stenosis, unstable CAD, recent stroke or TIA, haemodynamic instability, or other known morbidities associated with poor outcomes.
        <br><a href="https://doi.org/10.1093/europace/euv411" target="_blank" class="noMobile">
          2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
        </a>
        </div>
      </amp-fit-text>

    </figure>

    <!--MRI-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\CIEDs Safety MRI.png"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      MRI in patients with CIEDs<br> 
      MRI can be performed safely in non-MRI conditional devices as long as a number of precautions are taken.<br>
      <i class="ref">
        <a href="https://doi.org/10.1016/j.hrthm.2017.04.025" target="_blank">
          2017 HRS Expert Consensus</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    </amp-carousel>
</section>

<!--Complications-->
<section class="main lightBlue1">
  <h4 class="lightBlue1">
  <span class="showMore"><i class="fas fa-chevron-circle-down"></i>&nbsp; </span>
  <span class="showLess"><i class="fas fa-chevron-circle-up"></i>&nbsp; </span>  
  Complications</h4>
  
  <amp-carousel class="collapsible-captions" height="54vw" width="96vw" layout="fixed" type="slides" 
  style="margin-left: auto;margin-right: auto;">
  
    <!--complications 1-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\Tension-Pneumothorax.jpg" style="margin: 1vw;"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Complication: Pneumothorax</b><br>
      Risk factors for the development of a pneumothorax include: age >80â€‰years, female sex, low BMI, chronic obstructive pulmonary disease, and subclavian vein puncture.
      <br>
      <i class="ref">
        <a href="https://doi.org/10.1093/europace/euaa367" target="_blank">2021 EHRA Consensus</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
  </figure>

    <!--complications 2-->
    <figure>
      <amp-img layout="fill" src="media\Clinical\Cardiac-Tamponade.jpg" style="margin: 1vw;"></amp-img>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Complication: Cardiac Tamponade</b><br>
      Cardiac tamponade perioperatively is due to lead perforation.
      It is strongly suggested by hemodynamic compromise and
      should be confirmed by echocardiography and treated with emergent pericardiocentesis.
      <br>
      <i class="ref">
        <a href="https://doi.org/10.1093/europace/euaa367" target="_blank">2021 EHRA Consensus</a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
    </figure>

    <!--complication table-->
    <figure>
      <amp-fit-text width="80vw" height="40vw" layout="responsive">
        <Table class="lightTable" style="margin: auto;">
          <div class="lightBlue1" style="padding: 1vmax;text-align: center;font-weight: 600;">
            Perioperative Complications You Need to Know.</div>
          <tr>
            <th>Complication</th><th class="noMobile">What is it?</th><th>What to do?</th>
          </tr>
          <tr>
            <td>Cardiac Tamponade</td>
            <td class="noMobile">Lead perforation causing blood leaking into the pericardiac space compressing the heart causing low cardiac output.</td>
            <td>Echocardiogram to confirm. Pericardiocentesis to release the fluid.</td>
          </tr>
          <tr>
            <td>Pneumothorax</td><td class="noMobile">Attempted subclavian puncture made a hole in the lung causing air leaks into the pleural space compressing the lung causing desaturation.</td>
            <td>Air leaks into the pleural space compressing the lung causing desaturation.</td>
          </tr>
          <tr>
            <td>Oversedation</td><td class="noMobile">Desaturation from hypoventilation or hypotension from vasodilatation.</td>
            <td>Maintain airways, hydration, +/- antidotes.</td>
          </tr>
        </Table>
      </amp-fit-text>
    </figure>

    <!--device infection: risk-->
    <figure>
        <amp-img layout="fill" src="media\Clinical\risksInfection.png"></amp-img>
        <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
        <b>Risk Factors for CIED Infection</b><br>
        The most important procedure-related risk factors are pocket hematoma, long-procedural time, and re-operation.<br>
        Staphylococcus aureus is the most common organism involved in acute CIED infections.
        <i class="ref">
          <a href="https://doi.org/10.1093/europace/euz246" target="_blank">
          2019 EHRA Consensus on CIED infections</a>
        </i>
        <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
        </figcaption>
    </figure>

     <!--device infection: Mx-->
      <figure>
        <amp-img layout="fill" src="media\Clinical\infectionAlgo.png"></amp-img>
        <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
        <b>Diagnostic and Management Algorithm</b><br>
        Definiteâ€™ CIED clinical pocket/generator infection = generator pocket shows swelling, erythema, warmth, pain, and purulent discharge/sinus
        formation OR deformation of pocket, adherence and threatened erosion OR exposed generator or proximal leads.<br>
        <i class="ref">
          <a href="https://doi.org/10.1093/europace/euz246" target="_blank">
          2019 EHRA Consensus on CIED infections</a>
        </i>
        <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
        </figcaption>
    </figure>

  </amp-carousel>
</section>


<!--EP procedures-->
<section class="main veryLightBlue">
    <h4 class="veryLightBlue">
    <span class="showMore"><i class="fas fa-chevron-circle-down"></i>&nbsp; </span>
    <span class="showLess"><i class="fas fa-chevron-circle-up"></i>&nbsp; </span>  
    Other EP Testing/Procedures</h4>
    
    <amp-carousel class="collapsible-captions" height="54vw" width="96vw" layout="fixed" type="slides" 
    style="margin-left: auto;margin-right: auto;">
    
    <!--cardiac monitor-->
    <figure>
    <amp-img layout="fill" src="media\Clinical\cardiacMonitor.png"></amp-img>
    <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
    <b>Ambulatory Cardiac Monitoring</b><br>
    <i class="ref">
      <a href="https://doi.org/10.1016/j.cjca.2019.12.023" target="_blank">
      2020 CCS Guidelines on Syncope
      </a>
    </i>
    <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
    </figcaption>
    </figure>

    <!--TTT-->
    <figure>
      <div class="row">
      <amp-img layout="responsive" width="1468" height="1127" src="media\Clinical\TTT.png" style="flex: 0.8;"></amp-img>
      
      <amp-fit-text width="1.2" height="1" layout="responsive" 
      style="flex: 1.2;padding: 1vmax;margin: 1vmax;">
      <ul class="lightList">
        <li>Test that creates changes in posture from lying to standing using to evaluate the cause of syncope.</li>
        <li>May use adjunctive agents (Isoproterenol or nitroglycerine) to improve sensitivity.</li>
        <li>Positive test = inducible presyncope or syncope with hypotension with or without bradycardia.</li>
        <li>Should be considered when the cause of syncope is uncertain. 
          <span class="noMobile">Usually includes atypical presentations, distinguishing from epilepsy, 
            non-hemodynamic collapse, or elderly with few clues in history.</span>
          </li>
      </ul>
      <span class="ref noMobile">
        <a href="https://doi.org/10.1016/j.cjca.2019.12.023" target="_blank">
          2020 CCS Guidelines on Syncope
          </a>
      </span>
      </amp-fit-text>
      </div>
    </figure>

    <!--Ep Study-->
    <figure>
      <div class="row">
      <amp-img layout="responsive" width="1" height="1" src="media\Clinical\EP study.png" style="flex: 0.6;">
        </amp-img>
      <div style="flex: 1.2;">
        <ul class="lightList">
        <div style="padding: 1vmax;" class="noMobile">Indications for Electrophysiologic Study</div>
        <li>Differentiate between nodal or infra-hisian block.</li>
        <li>Assess risk of ventricular arrhythmia in ICM, DCM, and ACHD.</li>
        <li class="noMobile">Not useful in HCM, LQTS, SQTS, CPVT, Early repolarization syndrome, and those who are already indicated for ICD.</li>
        </ul>
      </div>
      </div>
      <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
      <b>Indications for Electrophysiologic Study</b><br>
      <i class="ref">
        ICM: ischemic cardiomyopathy, DCM: dilated cardiomyopathy, ACHD: adult congenital heart disease,
         HCM: hypertrophic cardiomyopathy, LQTS: long QT syndrome, SQTS: short QT syndrome, CPVT: catacholinergic polymorphic VT.
         <br> Ref:
        <a href="https://doi.org/10.1161/CIR.0000000000000549" target="_blank">
        2017 SCD Guidelines
        </a>
      </i>
      <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
      </figcaption>
      </figure>

    </amp-carousel>
</section>

<!--Q&A-->
<section class="main nearBlack">
  <h4 class="nearBlack">
  <span class="showMore"><i class="fas fa-chevron-circle-down"></i>&nbsp; </span>
  <span class="showLess"><i class="fas fa-chevron-circle-up"></i>&nbsp; </span>  
  Qs & As</h4>
  
  <amp-carousel class="collapsible-captions" height="54vw" width="96vw" layout="fixed" type="slides" 
  style="margin-left: auto;margin-right: auto;">
  
  <!--Q1-->
  <figure>
    <amp-fit-text width="80vw" height="45vw" layout="responsive" max-font-size="28" 
        style="color: #f2f2f2;">
          <div class="qBox">
            Q1: A 76 year-old woman has shortness of breath 6 hours after undergoing a pacemaker. 
            The pacemaker was done via cephalic route. On physical examination, her chest is clear, her BP is 80/50 mmHg, and the rhythm is AV paced at 70 bpm. Which of the following is the most appropriate management?
            <ol class="qList">
              <li>Administer of furosemide.</li>
              <li>Administer of salbutamol.</li>
              <li>Echocardiogram.</li>
              <li>Chest X-ray.</li>
              <li>Intravenous fluid.</li>
            </ol>
          </div>
        </amp-fit-text>
  <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
    Q1: The answer is...<br>
    Answer: c.
    Think of cardiac tamponade for hypotension and shortness of breath shortly after a device implantation. Pneumothorax is an unlikely complication for cephalic access. Heart failure, asthma exacerbation, or dehydration are possible but does not require an emergent diagnosis and treatment the same way cardiac tamponade does.
  <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
  </figcaption>
  </figure>

  <!--Q2-->
  <figure>
    <amp-img layout="fill" src="media\QA\sqICD.png"></amp-img>
  <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
    Q2: Tracings from subcutaneous ICD
    <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
  </figcaption>
  </figure>  

  <!--Q2:Q-->
  <figure>
    <amp-fit-text width="85vw" height="50vw" layout="responsive" max-font-size="28" 
        style="color: #f2f2f2;">
      <div class="qBox">
        Q2: A 48 y/o woman  
        underwent implantation of a subcutaneous implantable cardioverter-defibrillator (ICD) 
        for primary prevention of sudden death. She presented 3 months later for a routine ICD device interrogation. 
        Her device setting and presenting rhythm are shown in the figure (a). Review of her stored electrograms (b) showed an untreated episode several weeks earlier.
        Which of the following is the next best step?  
        <ol class="qList">
          <li>Schedule follow-up for device interrogation in 3 months.</li>
          <li>Schedule the patient for a procedure to reposition the subcutaneous ICD lead.</li>
          <li>Change the sensing configuration to an another vector.</li>
          <li>Perform an exercise stress test.</li>
        </ol>
      </div>
        </amp-fit-text>
  <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
    Q2: The answer is...<br>
    Answer: d.
    At presentation, the patient is in sinus rhythm. At the programmed sensing configuration, each QRS complex is sensed appropriately. Thus, changing the sensing vector empirically to another configuration would not be indicated.
The stored electrogram demonstrates clear evidence of a change in QRS morphology associated with T-wave oversensing in the initial portion of the tracing. The electrogram by the end of the tracing is sensed appropriately and resembles the electrogram obtained at the patientâ€™s device interrogation on presentation. Since the device detected the rhythm as a ventricular arrhythmia, simply ignoring the observation would not be suggested. On the other hand, it is premature to consider repositioning the ICD lead. T wave oversensing is by far the most common cause of oversensing in the subcutaneous ICD and this is typically evaluated by ETT and changing the sensing vector.
The most likely explanation is that the patient develops a rate-related bundle branch block during which the current programmed sensing configuration cannot adequately distinguish between QRS complexes and T waves. Thus, an exercise stress test will be useful to optimize the sensing configuration using a template acquired during exercise when the rate related QRS morphology can be replicated.
  <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
  </figcaption>
  </figure>

  <!--Q3-->
  <figure>
    <div class="row">
      <amp-img layout="responsive" width="881" height="649" src="media\QA\Q12 pLSVC.png" style="flex: 1;"></amp-img>
    <amp-fit-text width="45vw" height="45vw" layout="responsive" max-font-size="28" 
        style="color: #f2f2f2;flex: 1;">
      <div class="qBox">Q3
        <ol class="qList">
          <li>Dextrocardia</li>
          <li>Image flipped from L to R</li>
          <li>Mustard Operation</li>
          <li>Persistent left superior vena cava</li>
          <li>Arterial implantation</li>
        </ol>
      </div>
        </amp-fit-text>
    </div>
  <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
    Q3: The answer is...<br>
    Answer: d.
    Left SVC drains through coronary sinus and into RA and RV.
  <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
  </figcaption>
  </figure>

  <!--Q4-->
  <figure>
    <amp-fit-text width="90vw" height="52vw" layout="responsive" max-font-size="28" 
        style="color: #f2f2f2;">
          <div class="qBox" style="padding: 1vmax;">
            Q4: An 82-year-old Caucasian male with ischemic cardiomyopathy, LVEF 0.10, 
            status/post single-chamber ICD, 
            progressive renal impairment, and 3 hospitalizations over the prior calendar year is re-hospitalized again.
            His device is interrogated and noted to be nearing end-of-life. 
            The patient and family express an interest in proceeding with less aggressive care.
            Which of the following is the best approach to management of the ICD?
            <ol class="qList">
              <li>Selective inactivation of shock therapies while maintaining back-up ventricular pacing.</li>
              <li>Elective generator change.</li>
              <li>Upgrade to a CRT-D.</li>
              <li>Electrophysiological study to evaluate for placement of an atrial lead.</li>
            </ol>
          </div>
        </amp-fit-text>
  <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
    Q4: The answer is...<br>
    Answer: a. End-of-life care<br>
    The decision to inactivate the shock function of a defibrillator needs to take into account patient preferences and overall prognosis, especially when heart failure symptoms have progressed despite optimal medical therapy. ACC/AHA guidelines suggest that a reasonable prognosis for survival of at least 1 year applies to de novo implants; the same applies to generator changes.
    <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
  </figcaption>
  </figure>

  <!--Q5-->
  <figure>
    <amp-fit-text width="90vw" height="52vw" layout="responsive" max-font-size="28" 
        style="color: #f2f2f2;">
          <div class="qBox" style="padding: 1vmax;">
            Q5: A 70 year-old woman undergoes AV node ablation and CRT implantation for chronic AF and poor LVEF. 
            Which of the following is the most likely reason for setting the initial lower rate of the device to 90 bpm?
            <ol class="qList">
              <li>To improve cardiac output.</li>
              <li>To regularize ventricular rate.</li>
              <li>To avoid ventricular tachycardia.</li>
              <li>To enhance biventricular pacing.</li>
              <li>To improve ventricular remodelling.</li>
            </ol>
          </div>
        </amp-fit-text>
  <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
    Q5: The answer is...<br>
    Answer: c. Rapid V pacing to prevent torsades.<br>
    Sudden death secondary to torsades de pointes or ventricular fibrillation has been reported after AV junction ablation. This outcome is possibly related to increased dispersion of ventricular refractoriness produced by sudden heart rate slowing and ventricular pacing. After ablation, the ventricular pacing rate is usually set between 90 bpm and 100 bpm and then gradually tapered over several months.
    <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
  </figcaption>
  </figure>

  <!--Q6-->
  <figure>
    <amp-fit-text width="90vw" height="52vw" layout="responsive" max-font-size="28" 
        style="color: #f2f2f2;">
          <div class="qBox" style="padding: 1vmax;">
            Q6: An 82-year-old male with ischemic cardiomyopathy, LVEF 0.10, 
            is re-hospitalized and placed on dobutamine for several days. 
            His device is interrogated and noted to be nearing end-of-life (within 1-3 months). 
            The patient and family express an interest in proceeding with less aggressive care. <br>
            At this juncture, which of the following is the best approach to management of the ICD?
            <ol class="qList">
              <li>Selective inactivation of shock therapies while maintaining back-up ventricular pacing.</li>
              <li>Elective generator change.</li>
              <li>Upgrade to a CRT-D.</li>
              <li>Electrophysiological study to evaluate for placement of an atrial lead.</li>
              <li>Use of a beta-blocker with intrinsic sympathomimetic activity.</li>
            </ol>
          </div>
        </amp-fit-text>
  <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
    Q6: The answer is...<br>
    Answer: a. End-of-life situation. <br>
    Patients with refractory HF symptoms, refractory sustained VA, or nearing the end of life from other illness, clinicians should discuss ICD shock deactivation and consider the patientsâ€™ goals and preferences.
    <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
  </figcaption>
  </figure>

  <!--Q7-->
  <figure>
    <div class="row">
      <amp-fit-text width="90vw" height="52vw" layout="responsive" max-font-size="28" 
        style="color: #f2f2f2;flex: 1;">
      <div class="qBox">Q7: In children required pacing support, what is/are the advantage of epicardial lead over endocardial lead?
        <ol class="qList">
          <li>Lower chronic pacing threshold</li>
          <li>Lower risk of lead failure</li>
          <li>Preserves venous access</li>
          <li>All of the above</li>
        </ol>
      </div>
        </amp-fit-text>
    </div>
  <figcaption on="tap:AMP.setState({expanded: !expanded})" tabindex="0" role="button" [class]="expanded ? 'expanded' : ''">
    Q7: The answer is...<br>
    Answer: c.
    Epicardial lead implantation requires sternotomy or thoracotomy or subxiphoid approach, and is associated with higher chronic stimulation threshold, higher lead failures and fractures, and early depletion of battery life.<br>
    However, it preserves the venous access for future use for children.
    <div class="ref">
    <a href="https://doi.org/10.4103%2F0974-2069.107234" target="_blank">
      Ann Pediatr Cardiol. 2013.
    </a></div>
  <span [text]="expanded ? 'â–¼' : 'â–²'">â–²</span>
  </figcaption>
  </figure>



  </amp-carousel>
</section>



</amp-accordion>


<!--footer-->
<div id="about" style="background-color: #555;color: white;font-size: 18px;padding: 15vh 3vh">
    <div style="max-width: 600px;margin-left: auto;margin-right: auto;text-align: center;">
  
      <div class="rowF">
        <a href="#top" style="text-decoration:none;color: white;">
        <b>Top</b> of the page</a>
        </div>
  
      <div class="rowF">
        <b>follow </b>&nbsp; me at &nbsp;
          <a href="https://heartrhythmbox.com">
            <amp-img src="box_grey.png" width="28" height="28" layout="fixed">
            </amp-img></a>&nbsp;&nbsp; and &nbsp;&nbsp;
        <a href="https://www.facebook.com/HeartRhythmBox/" target="_blank" 
            style="text-decoration:none;color: white;">
            <amp-img src="fb.png" width="23" height="23" layout="fixed" style="vertical-align: -5px;">
            </amp-img>
        </a>
      </div>
  
      <div class="rowF" style="text-align: left;">
        <h2 class="sectionH">About the page</h2>
        <p class="sectionT">Heart Rhythm Box is a collection of web-paged style presentations in clinical cardiac electrophysiology topics.
            The page is created mainly for educational purpose. 
            I believe that presentations should be more interactive and easily accessible. 
            No need to register or download. You can access everything at your fingertips.
        </p>
      </div>        
      <div class="rowF" style="text-align: left;">       
                <h2 class="sectionH">About the author</h2>
                <p class="sectionT">
                  <i>t'</i> Thon, the screen name of the author, is a novice web developer,
                  a wine enthusiast, and a cardiac eletrophysiologist by training.
                </p>
             
          
      </div>
  
      <div class="rowF" style="border-bottom: none;">
          <a href="https://github.com/tTHon/heartrhythmbox" target="_blank" 
          style="text-decoration:none;color: white;">
          Know more about my code: &nbsp;
          <amp-img src="github white.png" width="23" height="23" layout="fixed" style="vertical-align: -3px;">
        </amp-img>
         
          </a>
      </div>
  
    </div>
  </div>

</body>
</html>